Dilpacimab (ABT165) is a dual-variable domain immunoglobulin engineered for high potency, simultaneously targeting the delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways. This bifunctional antibody is designed to inhibit two critical signaling pathways involved in angiogenesis and tumor growth, making it a valuable tool for cancer research. Dilpacimab is suitable for use in various experimental settings to explore the role of these pathways in oncogenesis and potential therapeutic interventions.
Dilpacimab (ABT165) is a dual-variable domain immunoglobulin engineered for high potency, simultaneously targeting the delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways. This bifunctional antibody is designed to inhibit two critical signaling pathways involved in angiogenesis and tumor growth, making it a valuable tool for cancer research. Dilpacimab is suitable for use in various experimental settings to explore the role of these pathways in oncogenesis and potential therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
